Kayton M L, Rowe D H, O'Toole K M, Thompson R B, Schwarz M A, Stolar C J, Kandel J J
Division of Pediatric Surgery, College of Physicians & Surgeons, Columbia University, Babies & Children's Hospital of New York, NY 10032, USA.
J Pediatr Surg. 1999 May;34(5):743-7; discussion 747-8. doi: 10.1016/s0022-3468(99)90367-6.
BACKGROUND/PURPOSE: The growth and spread of solid tumors are critically dependent on the induction of angiogenesis. We hypothesized that vascular endothelial growth factor (VEGF) would be detected in Wilms' tumors, and that both growth and metastasis would parallel VEGF levels in a murine model.
Primary tumors were established in the right kidneys of nude mice (n = 21). Mice were killed at 3, 4.5, or 6 weeks. Tumor-bearing and control kidneys were subjected to enzyme-linked immunosorbent assay (ELISA) for VEGF. Representative sections were assessed by histology and immunohistochemistry. Lungs were examined for metastases. Clinical specimens of Wilms' tumor (n = 12) also were assayed for VEGF.
The authors detected VEGF by ELISA with increasing frequency, and in increasing quantity, as experimental Wilms' tumors were grown over time. Immunohistochemistry demonstrated accumulation of VEGF in areas of viable tumor. Lung metastases occurred in 8 of 10 animals with VEGF-positive tumors, but in only 3 of 11 animals with VEGF-negative tumors, an association that was statistically significant. VEGF was found in 10 of 12 clinical Wilms' tumor specimens tested.
VEGF is present in both clinical and experimental Wilms' tumors. In a murine model, absolute VEGF levels increase as primary tumors grow, and VEGF production is significantly associated with tumor metastasis.
背景/目的:实体瘤的生长和扩散严重依赖于血管生成的诱导。我们假设在肾母细胞瘤中可检测到血管内皮生长因子(VEGF),并且在小鼠模型中,生长和转移情况将与VEGF水平平行。
在裸鼠(n = 21)的右肾中建立原发性肿瘤。在3、4.5或6周时处死小鼠。对荷瘤肾和对照肾进行VEGF的酶联免疫吸附测定(ELISA)。通过组织学和免疫组织化学评估代表性切片。检查肺部是否有转移。还对12例肾母细胞瘤临床标本进行了VEGF检测。
随着实验性肾母细胞瘤随时间生长,作者通过ELISA检测到VEGF的频率增加,数量也增加。免疫组织化学显示VEGF在存活肿瘤区域积聚。在10只VEGF阳性肿瘤动物中,有8只发生了肺转移,但在11只VEGF阴性肿瘤动物中,只有3只发生了肺转移,这种关联具有统计学意义。在12例检测的肾母细胞瘤临床标本中,有10例发现了VEGF。
VEGF存在于临床和实验性肾母细胞瘤中。在小鼠模型中,随着原发性肿瘤的生长,VEGF的绝对水平升高,并且VEGF的产生与肿瘤转移显著相关。